Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$88.14 AUD
Change Today -1.72 / -1.91%
Volume 1.1M
CSL On Other Exchanges
As of 2:10 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul R. Perreault BA Psychology

Chief Executive Officer, Managing Director, Executive Director and Member of Innovation & Development Committee, CSL Ltd.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Paul R. Perreault, BA (Psychology), has been the Chief Executive Officer and Managing Director of CSL Ltd. since July 1, 2013. Mr. Perreault serves as the Chief Executive Officer and Managing Director of CSL Behring LLC. He has more than 25 years of healthcare industry experience. He served as the President of CSL Behring UK Limited. He was responsible for all sales, marketing and commercial development activities at CSL Behring. Mr. Perreault served as an Executive ...

Read Full Background

Corporate Headquarters*

45 Poplar Road
Parkville, Victoria 3052


Phone: 61 3 9389 1911
Fax: 61 3 9389 1434

Board Members Memberships*

Chief Executive Officer, Managing Director, Executive Director and Member of Innovation & Development Committee


University of Central Florida

Other Affiliations*

Annual Compensation*

Total Annual Compensation$3,104,490

Stock Options*

Restricted Stock Awards$564,543
Long Term Incentive Plan$591,143
All Other Compensation$806,493
Exercised Options23,780
Unexercisable Options51,520
Total Number of Options75,300

Total Compensation*

Total Annual Cash Compensation$3,910,983
Total Short Term Compensation$3,104,490
Other Long Term Compensation$1,371,036
Total Calculated Compensation$5,118,586
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSL:AU A$88.14 AUD -1.72


Jean-Pierre Clamadieu Chief Executive Officer, Director and Member of Finance Committee
Solvay SA
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
Victor Grifols Roura Chairman, Chief Executive Officer, President and Member of Appointments & Remuneration Committee
Grifols, S.A.
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSL LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at